SB3

trastuzumab biosimilar · Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SB3, covering 2016-09-29 to 2019-04-02. Get the full timeline:

Most recent: Clinical Trial Update: SB3 Battery Life Observational Study